Schroeder Comments on MMA Fighter’s Appeal of NLRB Decision
September 27, 2018
Bloomberg Law
Partner Don Schroeder was quoted in a Bloomberg Law article, “Mixed Martial Artist Hopes Her KO’d Case Gets Revived,” about MMA fighter Leslie Smith’s plan to appeal the NLRB’s rejection of her allegations of labor law violations by the UFC.
Schroeder said retaliation for protected activity complaints can be made to the state human rights commission, the labor office or the EEOC. He also noted that California labor laws are worker-friendly, which could benefit Smith.
If those remedies are exhausted, Schroeder added, Smith could file a lawsuit claiming retaliation under the Fair Labor Standards Act. “Nothing would prevent her from going to federal court to file either individually or for a class action under the FLSA,” he said.
Schroeder said retaliation for protected activity complaints can be made to the state human rights commission, the labor office or the EEOC. He also noted that California labor laws are worker-friendly, which could benefit Smith.
If those remedies are exhausted, Schroeder added, Smith could file a lawsuit claiming retaliation under the Fair Labor Standards Act. “Nothing would prevent her from going to federal court to file either individually or for a class action under the FLSA,” he said.
People
Related News
June 22, 2026
In the News
Aaron Maguregui Authors Article on Building Scalable, Secure AI Strategies
Foley & Lardner LLP partner Aaron Maguregui authored the HealthTech article, “A Digital Health CEO’s Guide to Fast, Secure Scaling of AI,” offering guidance to digital health leaders on artificial intelligence scaling.
June 5, 2026
In the News
Jeffrey Blease Featured Across the Media for Litigation Department Chair Appointment
Foley & Lardner LLP partner Jeffrey Blease is featured across legal media for his recent appointment as chair of the firm's national litigation department.
June 5, 2026
In the News
David Rosen Discusses SCOTUS Ruling on Generic Drug Labeling
Foley & Lardner LLP partner David Rosen is quoted across the media for his analysis of the U.S. Supreme Court case Hikma Pharmaceuticals v. Amarin Pharma.